Literature DB >> 25281357

Basic obstetric pharmacology.

Yang Zhao1, Mary F Hebert2, Raman Venkataramanan3.   

Abstract

Pregnancy is associated with a variety of physiological changes that can alter the pharmacokinetics and pharmacodynamics of several drugs. However, limited data exists on the pharmacokinetics and pharmacodynamics of the majority of the medications used in pregnancy. In this article, we first describe basic concepts (drug absorption, bioavailability, distribution, metabolism, elimination, and transport) in pharmacokinetics. Then, we discuss several physiological changes that occur during pregnancy that theoretically affect absorption, distribution, metabolism, and elimination. Further, we provide a brief review of the literature on the clinical pharmacokinetic studies performed in pregnant women in recent years. In general, pregnancy increases the clearance of several drugs and correspondingly decreases drug exposure during pregnancy. Based on current drug exposure measurements during pregnancy, alterations in the dose or dosing regimen of certain drugs are essential during pregnancy. More pharmacological studies in pregnant women are needed to optimize drug therapy in pregnancy.
Copyright © 2014. Published by Elsevier Inc.

Entities:  

Keywords:  Pharmacokinetics; Pharmacology; Pregnancy; clinical pharmacology; placental transfer

Mesh:

Year:  2014        PMID: 25281357      PMCID: PMC5771662          DOI: 10.1053/j.semperi.2014.08.011

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  98 in total

1.  Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre- and postnatal human liver.

Authors:  Zhengbo Duanmu; Amy Weckle; Sevasti B Koukouritaki; Ronald N Hines; Josie L Falany; Charles N Falany; Thomas A Kocarek; Melissa Runge-Morris
Journal:  J Pharmacol Exp Ther       Date:  2005-12-09       Impact factor: 4.030

2.  Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxel.

Authors:  J G C van Hasselt; K van Calsteren; L Heyns; S Han; M Mhallem Gziri; J H M Schellens; J H Beijnen; A D R Huitema; F Amant
Journal:  Ann Oncol       Date:  2014-04-08       Impact factor: 32.976

3.  Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women.

Authors:  Jashvant D Unadkat; Diane W Wara; Michael D Hughes; Anita A Mathias; Diane T Holland; Mary E Paul; James Connor; Sharon Huang; Bach-Yen Nguyen; D Heather Watts; Lynne M Mofenson; Elizabeth Smith; Paul Deutsch; Kathleen A Kaiser; Ruth E Tuomala
Journal:  Antimicrob Agents Chemother       Date:  2006-12-11       Impact factor: 5.191

4.  Population pharmacokinetics of nevirapine in HIV-1-infected pregnant women and their neonates.

Authors:  Sihem Benaboud; Didier K Ekouévi; Saik Urien; Elisabeth Rey; Elise Arrivé; Stéphane Blanche; Glenda Gray; Kruy Leang Sim; Divine Avit; James McIntyre; Eric Nerrienet; François Dabis; Jean-Marc Tréluyer; Déborah Hirt
Journal:  Antimicrob Agents Chemother       Date:  2010-10-18       Impact factor: 5.191

5.  Lopinavir tablet pharmacokinetics with an increased dose during pregnancy.

Authors:  Brookie M Best; Alice M Stek; Mark Mirochnick; Chengcheng Hu; Hong Li; Sandra K Burchett; Steven S Rossi; Elizabeth Smith; Jennifer S Read; Edmund V Capparelli
Journal:  J Acquir Immune Defic Syndr       Date:  2010-08       Impact factor: 3.731

6.  Pharmacokinetic properties of sulfadoxine-pyrimethamine in pregnant women.

Authors:  Harin A Karunajeewa; Sam Salman; Ivo Mueller; Francisca Baiwog; Servina Gomorrai; Irwin Law; Madhu Page-Sharp; Stephen Rogerson; Peter Siba; Kenneth F Ilett; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

7.  Free and total plasma levels of lopinavir during pregnancy, at delivery and postpartum: implications for dosage adjustments in pregnant women.

Authors:  Aurélie Fayet-Mello; Thierry Buclin; Nicole Guignard; Sandra Cruchon; Matthias Cavassini; Claudia Grawe; Erika Gremlich; Karoline Aebi Popp; Flavia Schmid; Chin B Eap; Amalio Telenti; Jérôme Biollaz; Laurent A Decosterd; Begoña Martinez de Tejada
Journal:  Antivir Ther       Date:  2012-08-22

8.  Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartum.

Authors:  J S Read; B M Best; A M Stek; C Hu; E V Capparelli; D T Holland; S K Burchett; M E Smith; E C Sheeran; W T Shearer; I Febo; M Mirochnick
Journal:  HIV Med       Date:  2008-09-14       Impact factor: 3.180

9.  Modulation of human placental P-glycoprotein expression and activity by MDR1 gene polymorphisms.

Authors:  Sarah J Hemauer; Tatiana N Nanovskaya; Sherif Z Abdel-Rahman; Svetlana L Patrikeeva; Gary D V Hankins; Mahmoud S Ahmed
Journal:  Biochem Pharmacol       Date:  2009-11-06       Impact factor: 5.858

10.  Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice.

Authors:  M F Hebert; X Ma; S B Naraharisetti; K M Krudys; J G Umans; G D V Hankins; S N Caritis; M Miodovnik; D R Mattison; J D Unadkat; E J Kelly; D Blough; C Cobelli; M S Ahmed; W R Snodgrass; D B Carr; T R Easterling; P Vicini
Journal:  Clin Pharmacol Ther       Date:  2009-03-18       Impact factor: 6.903

View more
  13 in total

Review 1.  [Anesthesia and pain management during pregnancy].

Authors:  T Ninke; S Thoma-Jennerwein; J Blunk; T Annecke
Journal:  Anaesthesist       Date:  2015-05       Impact factor: 1.041

Review 2.  Anatomical and physiological alterations of pregnancy.

Authors:  Jamil M Kazma; John van den Anker; Karel Allegaert; André Dallmann; Homa K Ahmadzia
Journal:  J Pharmacokinet Pharmacodyn       Date:  2020-02-06       Impact factor: 2.745

Review 3.  Management of epilepsy during pregnancy: an update.

Authors:  Sima I Patel; Page B Pennell
Journal:  Ther Adv Neurol Disord       Date:  2015-12-27       Impact factor: 6.570

Review 4.  The impact of exposure to antidepressant medications during pregnancy on neonatal outcomes: a review of retrospective database cohort studies.

Authors:  Casey R Tak; Kathleen M Job; Katie Schoen-Gentry; Sarah C Campbell; Patrick Carroll; Maged Costantine; Diana Brixner; Angela K Birnbaum; Catherine M T Sherwin
Journal:  Eur J Clin Pharmacol       Date:  2017-06-09       Impact factor: 2.953

5.  Evaluation of Fetal and Maternal Vancomycin-Induced Kidney Injury during Pregnancy in a Rat Model.

Authors:  Medha D Joshi; Gwendolyn M Pais; Jack Chang; Khrystyna Hlukhenka; Sean N Avedissian; Anil Gulati; Walter C Prozialeck; Peter C Lamar; Zhong Zhang; Marc H Scheetz; Brooke Griffin
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

Review 6.  Reproductive Decision-Making Capacity in Women With Psychiatric Illness: A Systematic Review.

Authors:  Nina E Ross; Tinsley G Webster; Camille A Tastenhoye; Alisse K Hauspurg; Jill E Foust; Priya R Gopalan; Susan Hatters Friedman
Journal:  J Acad Consult Liaison Psychiatry       Date:  2021-08-27

Review 7.  Pharmacokinetic studies in pregnancy.

Authors:  Michael J Avram
Journal:  Semin Perinatol       Date:  2020-01-27       Impact factor: 3.300

8.  Special population considerations and regulatory affairs for clinical research.

Authors:  Kristin N Grimsrud; Catherine M T Sherwin; Jonathan E Constance; Casey Tak; Athena F Zuppa; Michael G Spigarelli; Nicole L Mihalopoulos
Journal:  Clin Res Regul Aff       Date:  2015

9.  Ondansetron Exposure Changes in a Pregnant Woman.

Authors:  Lara S Lemon; Hongfei Zhang; Mary F Hebert; Gary D Hankins; David M Haas; Steve N Caritis; Raman Venkataramanan
Journal:  Pharmacotherapy       Date:  2016-07-25       Impact factor: 4.705

Review 10.  The Treatment of Colorectal Cancer During Pregnancy: Cytotoxic Chemotherapy and Targeted Therapy Challenges.

Authors:  Jane E Rogers; Arvind Dasari; Cathy Eng
Journal:  Oncologist       Date:  2016-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.